Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
AstraZeneca
H. Lee Moffitt Cancer Center and Research Institute
University Hospital, Toulouse
VA Office of Research and Development
University of Colorado, Denver
Brigham and Women's Hospital
NiKang Therapeutics, Inc.
Pfizer
University of Alabama at Birmingham